Page last updated: 2024-08-23

mifepristone and Malignant Fibrohistiocytic Tumors

mifepristone has been researched along with Malignant Fibrohistiocytic Tumors in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Check, D; Check, JH; Cohen, R; Dix, E; Wilson, C	1

Other Studies

1 other study(ies) available for mifepristone and Malignant Fibrohistiocytic Tumors

Article	Year
Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types. Anticancer research, 2010, Volume: 30, Issue:2 Topics: Adult; Aged; Carcinoma, Transitional Cell; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Hormone Antagonists; Humans; Kidney Neoplasms; Leiomyosarcoma; Male; Middle Aged; Mifepristone; Neoplasms; Palliative Care; Pancreatic Neoplasms; Receptors, Progesterone; Survival Rate; Thymus Neoplasms; Treatment Outcome; Young Adult	2010

Article

Year

Efficacy of the progesterone receptor antagonist mifepristone for palliative therapy of patients with a variety of advanced cancer types.

Anticancer research, 2010, Volume: 30, Issue:2

Topics: Adult; Aged; Carcinoma, Transitional Cell; Colonic Neoplasms; Female; Histiocytoma, Malignant Fibrous; Hormone Antagonists; Humans; Kidney Neoplasms; Leiomyosarcoma; Male; Middle Aged; Mifepristone; Neoplasms; Palliative Care; Pancreatic Neoplasms; Receptors, Progesterone; Survival Rate; Thymus Neoplasms; Treatment Outcome; Young Adult

2010